|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Phase Ⅲ trial of doxorubicin, paclitaxel, and the combination of doxorubicin and paclitaxel as front-line chemotherapy for metastatic breast cancer: an intergroup trial(E1193) 显示文摘 | Sledge GW Neuberg D Bernardo P | 2003 | J Clin Oncol2003，21，4： | 1 |
| 2 | Angiogenesis and antiangiogenic therapy显示文摘 | Miller K D | 2002 | Curr ProblCaacer2002，26，1： | 1 |
| 3 | Phase Ⅲ trial of doxorubicin vs paclitaxel vs doxorubicin + paclitaxel as first- line therapy for metastatic cancer: an intergroup trial显示文摘 | Sledge G N Neuberg D Ingle S | 1997 | J Clin Oncol1997，16，： | 1 |
| 4 | Phase Ⅲ trial of doxo- rubicin, paclitaxel, and the combination of doxorubicin and pacli- taxel as front-line chemotherapy for metastatic breast cancer: an intergroup trial (El193) 显示文摘 | Sledge G Neuberg D Bermardo P | 2003 | J Clin Oncol2003，21，4： | 1 |
| 5 | Buspirone,chlordiazepoxide and diazepam effects in a zebrafish model of anxiety显示文摘 | Bencan Z Sledge D Levin ED | 2009 | Pharmacol Biochem Behavior2009，94，： | 1 |
| 6 | Irreducible dislocations of the cervical spine with a prolapsed disc: preliminary results from a treatment technique显示文摘 | Allred C D Sledge J B | 2001 | Spine2001，26，17： | 1 |
| 7 | Phase III trial of doxorubicin,paclitaxel,and the combination of doxorubicin and paclitaxel as front-line chemotherapy for metastatic breast cancer:an intergroup trial (E1193) 显示文摘 | Sledge GW Neuberg D Bernardo P | 2003 | J Clin Oncol2003，21，4： | 1 |
| 8 | Phase Ⅲ trial of doxorubicin, paclitaxel, and the combination of doxorubicin and paclitaxel as front - line chemotherapy for metastatic breast cancer: an intergroup trial(E1193)显示文摘 | Neuberg D Bernardo P | 2003 | J Clin Oncol2003，21，4： | 1 |
| 9 | Redefining the target:chemotherapeutics as antiangiogenics显示文摘 | Miller K D Sweeney C J Sledge G W Jr | 2001 | J Clin Oncol2001，19，4： | 1 |
| 10 | Making personalized cancer medicine a reality:challenges and op- portunities in the development of biomarkers and companion diagnostics 显示文摘 | Parkinson D R Johnson B E Sledge G W | 2012 | Clinical Cancer Research2012，18，3： | 1 |
| 11 | Buspirone,chlordiazepoxide and diazepam effects in a zebrafish model of anxiety显示文摘 | Bencan Z Sledge D Levin ED | 2009 | Pharmacol Biochem Behav2009，94，： | 1 |
| 12 | Phase III trial of doxorubicin, paclitaxel, and the combination of doxorubicin and paclitaxel as front-line chemotherapy for metastatic breast cancer: an intergroup trial (E1193)显示文摘 | Sledge GW Neuberg D Bemardo P | 2003 | J Clin Oncl2003，21，4： | 1 |
| 13 | Medicago truncatula ESTSSRs reveal cross-species genetic markers for Medicago spp显示文摘 | Sledge M K Wang L May G D Chekhovskiy K Zwonitzer J C Mian M A R | 2004 | Theor Appl Genet2004，108，3： | 1 |
| 14 | Redefining the target:chemotherapeutics as antiangi0genics显示文摘 | Miller K D Sweeney C J Sledge G W | 2001 | J Clin Oncol2001，19，4： | 1 |
| 15 | Phase Ⅲ trial of doxorubicin, paclitaxel, and the combination of doxorubicin and paclitaxel as front-line chemotherapy for metastatic breast cancer:an intergroup trial ( E1193 ) 显示文摘 | Sledge GW Neuberg D Bernardo P | 2003 | J Clin Oncol2003，21，4： | 1 |
| 16 | Redefining the target: chemotherapeutics as antiangiogenies 显示文摘 | MILLER K D SWEENEY C J SLEDGE G W | 2001 | J Clin Oncol2001，19，4： | 1 |
| 17 | Phase Ⅲ trial of doxombiein, paelitaxel, and the combination of doxorubicin and paclitaxel as front-line chemotherapy for metastatic breast cancer: an intergroup lrial(E 1193)显示文摘 | Sledge GW Neuberg D Bemardo P | 2003 | J Clin Oncol2003，21，4： | 1 |
| 18 | Redefi-ning the target: chemotherapeutics as antiangiogenics显示文摘 | MILLER K D SWEENEY C J SLEDGE G W J R | 2001 | J Clin Oncol2001，19，4： | 1 |
| 19 | Phase Ⅲ trial of doxorubicin,paclitaxel,and the combination of doxorubicin and paclitaxel as front-line chemotherapy for metastatic breast cancer:An intergroup trial(E1193)显示文摘 | Sledge GW Neuberg D Bernardo P | 2003 | J Clin Oncol2003，21，： | 1 |
| 20 | Medicago truncatula EST-SSRs reveal cross-species genetic markers for Medicago spp显示文摘 | Eujayl I Sledge M K Wang L May G D Chekhovskiy K Zwonitzer J C Mian M A | | 0，，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员